Barry E. Greene, President and COO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 33,200 shares at $89.11 ($3.0M) on 2014-11-17, disclosed to the SEC on 2014-11-19.
Scheduled sale ($3.0M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.11 | 18,059 | $1.6M | 54.1% |
| 2 | $89.81 | 9,579 | $860K | 28.9% |
| 3 | $90.96 | 5,462 | $497K | 16.7% |
| 4 | $93.99 | 100 | $9K | 0.3% |
| Total | $89.63 avg | 33,200 | $3.0M | 100% |
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |